Correction of metabolic acidosis after conversion from sevelamer hydrochloride to lanthanum carbonate. [PDF]
Lindley E, Tattersall J, Wright M.
europepmc +1 more source
From bench to bedside: Overcoming translational hurdles in nanoparticle research with pharmacokinetic modeling. [PDF]
Parrot M +6 more
europepmc +1 more source
Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management. [PDF]
Raju S, Saxena R.
europepmc +1 more source
Efficacy of tenapanor in managing hyperphosphatemia and constipation in hemodialysis patients: A randomized controlled trial. [PDF]
Suzuki N +12 more
europepmc +1 more source
Sevelamer-induced Gastrointestinal Mucosal Injury: A Critical Review for Clinicians. [PDF]
Bathobakae L +10 more
europepmc +1 more source
Efficacy and Safety of Phosphate-Lowering Agents for Adult Patients with CKD Requiring Dialysis: A Network Meta-Analysis. [PDF]
Nishimoto M +13 more
europepmc +1 more source
Adherence to the Dietary Index for Gut Microbiota and reduced risk of nephrolithiasis: a case-control study of Chinese adults. [PDF]
Jin X +7 more
europepmc +1 more source
Combination Oxylanthanum Carbonate and Tenapanor Lowers Urinary Phosphate Excretion in Rats. [PDF]
Medicherla S +4 more
europepmc +1 more source
Phosphate Binder Impairs Levothyroxine Absorption in a Hypothyroid Patient With End-Stage Renal Disease. [PDF]
Ko M, Barai R, Brent G.
europepmc +1 more source

